BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 375 participants.
Also called NCT01569178
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 375 participants
- Registry
-
NCT01569178
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Czechia, Denmark, Finland, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01569178. Randomized; no masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2019-11-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
- Acronym
- BAMI
- Condition
- Myocardial Infarction
- Condition
- Death
- Intervention (Procedure)
- Bone Marrow aspiration and intracoronary reinfusion
- Lead sponsor
- Queen Mary University of London
Record details
- Record id
cardio:ct-nct01569178- Content hash
7e6b3684e17937476826afc7b3c4738ec9603db4556cbea3c638ac559aa7a3d5